Cargando…
NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice
NaoXinTong Capsule (NXT), a Chinese medicine, is currently used to treat patients with cardiovascular and cerebrovascular diseases. Clinical observations indicate its anti-diabetic functions with unclear mechanisms. Herein, we report the effect of NXT on diabetic nephropathy (DN). Type 2 diabetic db...
Autores principales: | Yang, Shu, Liu, Mengyang, Chen, Yuanli, Ma, Chuanrui, Liu, Lipei, Zhao, Buchang, Wang, Yong, Li, Xiaoju, Zhu, Yan, Gao, Xiumei, Kong, Deling, Duan, Yajun, Han, Jihong, Yang, Xiaoxiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002396/ https://www.ncbi.nlm.nih.gov/pubmed/29904053 http://dx.doi.org/10.1038/s41598-018-26746-1 |
Ejemplares similares
-
NaoXinTong Inhibits the Development of Diabetic Retinopathy in db/db Mice
por: Liu, Mengyang, et al.
Publicado: (2015) -
Administration of Danhong Injection to diabetic db/db mice inhibits the development of diabetic retinopathy and nephropathy
por: Liu, Mengyang, et al.
Publicado: (2015) -
Systematical Identification of the Protective Effect of Danhong Injection and BuChang NaoXinTong Capsules on Transcription Factors in Cerebral Ischemia Mice Brain
por: Xu, Jing, et al.
Publicado: (2020) -
A Metabonomics Investigation into the Therapeutic Effects of BuChang NaoXinTong Capsules on Reversing the Amino Acid-Protein Interaction Network of Cerebral Ischemia
por: Xu, Jing, et al.
Publicado: (2019) -
Up-Regulation of CYP2C19 Expression by BuChang NaoXinTong via PXR Activation in HepG2 Cells
por: Sun, Hong, et al.
Publicado: (2016)